A blood RNA signature for tuberculosis disease risk: a prospective cohort study DE Zak, A Penn-Nicholson, TJ Scriba, E Thompson, S Suliman, LM Amon, ... The Lancet 387 (10035), 2312-2322, 2016 | 823 | 2016 |
Immunological biomarkers of tuberculosis G Walzl, K Ronacher, W Hanekom, TJ Scriba, A Zumla Nature Reviews Immunology 11 (5), 343-354, 2011 | 653 | 2011 |
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice RS Wallis, M Pai, D Menzies, TM Doherty, G Walzl, MD Perkins, A Zumla The lancet 375 (9729), 1920-1937, 2010 | 644 | 2010 |
Distinct, specific IL-17-and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response TJ Scriba, B Kalsdorf, DA Abrahams, F Isaacs, J Hofmeister, G Black, ... The Journal of Immunology 180 (3), 1962-1970, 2008 | 552 | 2008 |
Diagnostic tools in tuberculous pleurisy: a direct comparative study AH Diacon, BW Van de Wal, C Wyser, JP Smedema, J Bezuidenhout, ... European Respiratory Journal 22 (4), 589-591, 2003 | 552 | 2003 |
Genital inflammation and the risk of HIV acquisition in women L Masson, JAS Passmore, LJ Liebenberg, L Werner, C Baxter, KB Arnold, ... Clinical Infectious Diseases 61 (2), 260-269, 2015 | 468 | 2015 |
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies S Tiberi, N du Plessis, G Walzl, MJ Vjecha, M Rao, F Ntoumi, S Mfinanga, ... The Lancet Infectious Diseases 18 (7), e183-e198, 2018 | 404 | 2018 |
Human gene expression profiles of susceptibility and resistance in tuberculosis J Maertzdorf, D Repsilber, SK Parida, K Stanley, T Roberts, G Black, ... Genes & Immunity 12 (1), 15-22, 2011 | 382 | 2011 |
Tuberculosis: advances and challenges in development of new diagnostics and biomarkers G Walzl, R McNerney, N du Plessis, M Bates, TD McHugh, NN Chegou, ... The Lancet Infectious Diseases 18 (7), e199-e210, 2018 | 360 | 2018 |
Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure ST Malherbe, S Shenai, K Ronacher, AG Loxton, G Dolganov, M Kriel, ... Nature medicine 22 (10), 1094-1100, 2016 | 302 | 2016 |
Four-gene pan-African blood signature predicts progression to tuberculosis S Suliman, EG Thompson, J Sutherland, J Weiner 3rd, MOC Ota, ... American journal of respiratory and critical care medicine 197 (9), 1198-1208, 2018 | 283 | 2018 |
Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response JM Cliff, JS Lee, N Constantinou, JE Cho, TG Clark, K Ronacher, EC King, ... The Journal of infectious diseases 207 (1), 18-29, 2013 | 280 | 2013 |
Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression L Roberts, JAS Passmore, C Williamson, F Little, LM Bebell, K Mlisana, ... Aids 24 (6), 819-831, 2010 | 278 | 2010 |
A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes R Roy Chowdhury, F Vallania, Q Yang, CJ Lopez Angel, F Darboe, ... Nature 560 (7720), 644-648, 2018 | 264 | 2018 |
Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa K Mlisana, N Naicker, L Werner, L Roberts, F Van Loggerenberg, ... The Journal of infectious diseases 206 (1), 6-14, 2012 | 260 | 2012 |
Biomarkers of inflammation, immunosuppression and stress are revealed by metabolomic profiling of tuberculosis patients J Weiner 3rd, SK Parida, J Maertzdorf, GF Black, D Repsilber, A Telaar, ... PloS one 7 (7), e40221, 2012 | 256 | 2012 |
Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report NN Chegou, GF Black, M Kidd, PD Van Helden, G Walzl BMC pulmonary medicine 9, 1-12, 2009 | 222 | 2009 |
Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study L Masson, K Mlisana, F Little, L Werner, NN Mkhize, K Ronacher, ... Sexually transmitted infections 90 (8), 580-587, 2014 | 220 | 2014 |
Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis NN Chegou, J Heyckendorf, G Walzl, C Lange, M Ruhwald European Respiratory Journal 43 (5), 1472-1486, 2014 | 210 | 2014 |
Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-D-glucose positron emission and computed tomography H Esmail, RP Lai, M Lesosky, KA Wilkinson, CM Graham, AK Coussens, ... Nature medicine 22 (10), 1090-1093, 2016 | 205 | 2016 |